Identification of bio-functions of cancer stem-like cells and differentially expressed membrane proteins in side population cells from human epithelial ovarian cancer cell lines

doi:10.16352/j.issn.1001-6325.2022.02.004

Abstract

Abstract: Objective To validate the stemness bio-function of side population (SP) cells from epithelial ovarian cancer cell lines and to detect the differentially expressed cellular membrane proteins in SP cells. Methods SP cells of human ovarian cancer cell lines SKOV3 and A2780 which secreted bisbenzimide Hoechst33342 and located as side population were sorted by flow cytometry. Bio-functions of stemness of SP cells were validated. Through stable isotope labeling by amino acids in cell culture (SILAC), differentially expressed membrane proteins in SP cells were detected. Results SP cells of SKOV3 and A2780 were sorted successfully. The ratio of SP cells was about 0.5% and increased significantly through repeated sorting. SP cells differentiated into non-SP (NSP) cells. Stemness of SP cells was validated in vitro, including cell clone forming, resistance to cisplatin and paclitaxel in NOD/SCID mice. SILAC technique was used to detect differentially expressed membrane proteins in SP cells. Results showed that 1 561 and 1 989 differentially expressed proteins were detected respectively in SKOV3 and A2780 SP cells. Among those significantly up-regulated proteins in SKOV3 SP cells, 12 proteins were also up-regulated in A2780 SP cells. On the contrary, 13 proteins were down-regulated both in SKOV3 and A2780 SP cells. Conclusions SP cells of human epithelial ovarian cancer cells show stemness. And differently expressed membrane proteins in SP cells were detected which would be the base of further screening surface biomarker of ovarian cancer stem-like cells.

Key words: ovarian cancer, cancer stem-like cells, side population cells, surface biomarker, stable isotope labeling by amino acids in cell culture (SILAC)

CLC Number:

R737.31

YIN Jie, PAN Ling-ya, WEN Yi-ping, HUANG Hong, ZENG Jing, LI Xiao-ying, HAN Tian-tian, JIN Ying, LI Yan. Identification of bio-functions of cancer stem-like cells and differentially expressed membrane proteins in side population cells from human epithelial ovarian cancer cell lines[J]. Basic & Clinical Medicine, 2022, 42(2): 221-227.

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: http://journal11.magtechjournal.com/Jwk_jcyxylc/EN/10.16352/j.issn.1001-6325.2022.02.004

http://journal11.magtechjournal.com/Jwk_jcyxylc/EN/Y2022/V42/I2/221

References

[1]Wu C, Wei Q, Utomo V, et al. Side population cells isolated from mesenchymal neoplasms have tumor initiating potential[J]. Cancer Res, 2007, 67: 8216-8222.
[2]Reya T, Morrison SJ, Clarke MF, et al. Stem cells, cancer, and cancer stem cells[J]. Nature, 2001, 414: 105-111.
[3]Allikmets R, Schriml LM, Hutchinson A, et al. A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance[J]. Cancer Res, 1998, 58: 5337-5339.
[4]Szotek PP, Pieretti-Vanmarcke R, Masiakos PT, et al. Ovarian cancer side population defines cells with stem cell-like characteristics and mullerian inhibiting substance responsiveness[J]. Proc Natl Acad Sci U S A, 2006, 103: 11154-11159.
[5]Hirschmann-Jax C, Foster AE, Wulf GG, et al. A distinct “side population” of cells in human tumor cells: implications for tumor biology and therapy[J]. Cell Cycle, 2005, 4: 203-205.
[6]Nishimura F, Yoshikawa M, Kanda S, et al. Potential use of embryonic stem cells for the treatment of mouse parkinsonian models: improved behavior by transplanta-tion of in vitro differentiated dopaminergic neurons from embryonic stem cells[J]. Stem Cells, 2003, 21: 171-180.
[7]Alvi AJ, Clayton H, Joshi C, et al. Functional and molecular characterisation of mammary side population cells[J]. Breast Cancer Res, 2003, 5: R1-R8.
[8]Zhou S, Schuetz JD, Bunting KD, et al. The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype[J]. Nat Med, 2001, 7: 1028-1034.
[9]钟艳平, 孟泳圳, 李力, 等. 卵巢癌SKOV3细胞中侧群细胞的生物学特性[J]. 肿瘤防治研究, 2014, 41: 1282-1285.
[10]Price P, McMillan TJ. Use of the tetrazolium assay in measuring the response of human tumor cells to ionizing radiation[J]. Cancer Res, 1990, 50: 1392-1396.
[11]高红军, 孙玉琳,赵晓航. 细胞培养稳定同位素标记技术与肿瘤标志分子研究[J]. 基础医学与临床, 2007, 27: 113-121.
[12]Liang X, Zhao J, Hajivandi M, et al. Quantification of membrane and membrane-bound proteins in normal and malignant breast cancer cells isolated from the same patient with primary breast carcinoma[J]. J Proteome Res, 2006, 5: 2632-2641.
[13]Auersperg N, Wong AS, Choi KC, et al. Ovarian surface epithelium: biology, endocrinology, and pathology[J]. Endocr Rev, 2001, 22: 255-288.
[14]Hamburger AW, Salmon SE. Primary bioassay of human tumor stem cells[J]. Science, 1977, 197: 461-463.
[15]Natali PG, Nicotra MR, Sures I, et al. Expression of c-kit receptor in normal and transformed human nonly-mphoid tissues[J]. Cancer Res, 1992, 52: 6139-6143.
[16]Modlin IM, Kidd M, Lye KD, et al. Gastric stem cells: an update[J]. Keio J Med, 2003, 52: 134-137.
[17]Amanchy R, Kalume DE, Pandey A. Stable isotope labeling with amino acids in cell culture (SILAC) for studying dynamics of protein abundance and posttranslational modifications[J]. Sci STKE, 2005, 2005: pI2. doi: 10.1126/stke.2672005pl2.
[18]Ong SE, Foster LJ, Mann M. Mass spectrometric-based approaches in quantitative proteomics[J]. Methods, 2003, 29: 124-130.